Back |
home / stock / aqst / aqst message board
Subject | By | Source | When |
---|---|---|---|
12 down days in a row : ( | Aarin | investorshub | 07/14/2020 4:20:56 PM |
Filled at $4.25. Next buy will be | Aarin | investorshub | 07/10/2020 9:49:59 PM |
$4.52 was filled and I am adjusting my | Aarin | investorshub | 07/10/2020 4:40:48 PM |
I might get my $4.52 price today!.....next buy | Aarin | investorshub | 07/02/2020 3:12:33 PM |
Upcoming PDUFA 9/27/20 | DorseyE | investorshub | 06/03/2020 3:37:28 AM |
I hope you guys bought on the dip! | DorseyE | investorshub | 06/03/2020 3:35:35 AM |
This is going to be big!!!! $AQST$$$ | StocksNcash | investorshub | 06/01/2020 2:34:41 PM |
This technology is SUCH a big deal for | Aarin | investorshub | 05/30/2020 1:29:55 PM |
This is a great buy $$$$ FDA approval | StocksNcash | investorshub | 05/29/2020 7:24:11 PM |
Amen brother, great buying opportunity, gonna be another | DorseyE | investorshub | 05/27/2020 3:56:33 AM |
We will see but I am expecting $AQST | Aarin | investorshub | 05/26/2020 7:17:40 PM |
PDUFA 9/27/2020 | DorseyE | investorshub | 05/25/2020 8:23:16 AM |
Next catalysts? | Aarin | investorshub | 05/24/2020 10:45:41 AM |
Thanks brother. | DorseyE | investorshub | 05/24/2020 3:32:34 AM |
Thanks brother. | DorseyE | investorshub | 05/24/2020 3:32:32 AM |
I am not quite sure i understood what | midastouch017 | investorshub | 05/23/2020 11:38:27 AM |
I ate HUMBLE PIE all day Friday! | DorseyE | investorshub | 05/23/2020 8:55:09 AM |
Mazzel Tov DorseyE. | midastouch017 | investorshub | 05/22/2020 4:28:02 AM |
Tomboston: Look like target to $8-$10 after approval | Tomboston | investorshangout | 05/16/2020 8:09:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Aquestive Therapeutics Inc. Company Name:
AQST Stock Symbol:
NASDAQ Market:
Aquestive Therapeutics Inc. Website:
WARREN, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...
Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pH Remains on track to complete Anaphylm supportive clinical studies and expects to request pre-NDA meeting with FDA in the third quarter 2024 Continues to anticipate filin...
WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...